Raras
Buscar doenças, sintomas, genes...
Aspergilose broncopulmonar alérgica
ORPHA:1164CID-10 · B44.1+CID-11 · CA82.4OMIM 103920DOENÇA RARA

A aspergilose broncopulmonar alérgica (ABPA) é uma doença pulmonar rara que afeta o sistema imunológico. Ela é causada por uma reação exagerada do corpo (uma espécie de alergia forte) a um fungo chamado Aspergillus fumigatus. Clinicamente, manifesta-se com asma de difícil controle e o aparecimento repetido de inflamações ou "manchas" nos pulmões.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A aspergilose broncopulmonar alérgica (ABPA) é uma doença pulmonar rara que afeta o sistema imunológico. Ela é causada por uma reação exagerada do corpo (uma espécie de alergia forte) a um fungo chamado Aspergillus fumigatus. Clinicamente, manifesta-se com asma de difícil controle e o aparecimento repetido de inflamações ou "manchas" nos pulmões.

Pesquisas ativas
10 ensaios
44 total registrados no ClinicalTrials.gov
Publicações científicas
2.328 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: B44.1+
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
6 sintomas
🧠
Neurológico
1 sintomas
🛡️
Imunológico
1 sintomas
📏
Crescimento
1 sintomas
🩸
Sangue
1 sintomas
🦴
Ossos e articulações
1 sintomas

+ 4 sintomas em outras categorias

Características mais comuns

90%prev.
Anormalidade do sistema imunológico
Muito frequente (99-80%)
90%prev.
Tosse
Muito frequente (99-80%)
90%prev.
Asma
Muito frequente (99-80%)
90%prev.
Anormalidade dos eosinófilos
Muito frequente (99-80%)
55%prev.
Bronquiectasia
Frequente (79-30%)
55%prev.
Atrofia cortical cerebral
Frequente (79-30%)
15sintomas
Muito frequente (4)
Frequente (4)
Ocasional (6)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 15 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do sistema imunológicoAbnormality of the immune system
Muito frequente (99-80%)90%
TosseCough
Muito frequente (99-80%)90%
AsmaAsthma
Muito frequente (99-80%)90%
Anormalidade dos eosinófilosAbnormality of eosinophils
Muito frequente (99-80%)90%
BronquiectasiaBronchiectasis
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.328PubMed
Últimos 10 anos200publicações
Pico2025111 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 34
2Fase 22
·Pré-clínico14
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Aspergilose broncopulmonar alérgica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

44 ensaios clínicos encontrados, 10 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.036 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.036

#1

[A case of allergic bronchopulmonary aspergillosis complicated by pinworm infection in a child: immune interaction mechanism and stepwise treatment strategy].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2026 Feb 15

This article reports a rare pediatric case of allergic bronchopulmonary aspergillosis (ABPA) complicated by concurrent pinworm infection, highlighting immune interaction and individualized, stepwise management. A 10-year-7-month-old girl presented with recurrent cough and wheezing; laboratory testing showed marked eosinophilia (1.23×109/L) and elevated total immunoglobulin E (1 196 IU/mL). Aspergillus fumigatus IgG was 88.61 AU/mL, and Aspergillus fumigatus allergen m3-specific IgE was 0.37 IU/mL. Stool parasite examination confirmed pinworm infection. Chest computed tomography demonstrated atypical segmental pulmonary consolidation. Through multidisciplinary collaboration, stepwise anti-infective therapy (cefoperazone-sulbactam followed by imipenem and then voriconazole), pulsed anthelminthic therapy (albendazole), and immunomodulatory treatment were implemented, resulting in complete symptom resolution and sustained remission over 30 months of follow-up. This case illustrates a dynamic balance of Th2 immune polarization under parasitic-fungal co-infection and, for the first time, proposes a "parasite-fungus-immune memory triangle" conceptual model, offering insights for individualized management in complex pediatric infections. 该文报道1例罕见的儿童变应性支气管肺曲霉病合并蛲虫感染病例,探讨其免疫交互机制及个体化治疗策略。10岁7个月女性患儿,以反复咳嗽、喘息为主要表现,实验室检查显示嗜酸性粒细胞显著增多(1.23×10⁹/L),免疫球蛋白(immunoglobulin, Ig)E升高(1 196 IU/mL),烟曲霉IgG抗体(88.61 AU/mL)及烟曲霉m3过敏原特异性IgE抗体(0.37 IU/mL)升高,粪便寄生虫检测确诊蛲虫感染。肺部计算机断层扫描表现为非典型节段性肺实变。通过多学科协作,采用阶梯式抗感染(头孢哌酮舒巴坦→亚胺培南→伏立康唑)、脉冲式驱虫(阿苯达唑)及免疫调节治疗,随访30个月患儿症状完全缓解。该病例揭示了寄生虫-真菌共感染背景下辅助性T细胞2型免疫极化的动态平衡机制,首次提出“寄生虫-真菌-免疫记忆三角”模型,为复杂感染患儿的个体化管理提供新思路。.

#2

Establishment of a novel murine model of allergic bronchopulmonary aspergillosis using an eosinophilic mutant mouse.

The Journal of veterinary medical science2026 Jan 01

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disorder caused by chronic exposure to Aspergillus fumigatus (Af). Existing mouse models do not fully capture the severity of ABPA. This study developed a novel murine model of ABPA using the spontaneously eosinophilic Yama mouse. Female Yama and BALB/c mice were sensitized and challenged with Asp f1, a major allergen derived from Af. Peripheral eosinophil counts, serum IgE levels, and histopathological changes in the lungs, including goblet cell hyperplasia, mucus plugging, collagen deposition, eosinophil cationic protein (ECP), and CD117/c-kit expression, were assessed. Cytokine and fibrosis-related gene mRNA expression of interleukin-4 (IL-4), IL-5, IL-6, IL-13, transforming growth factor-β (TGF-β), and Col1a1 was also measured. Compared to BALB/c mice, Asp f1-challenged Yama mice exhibited sustained eosinophilia, increased IgE, pronounced goblet cell hyperplasia with mucus plugging, collagen deposition, and elevated eosinophil cationic protein (ECP) expression. Yama mice also showed more significant peribronchial inflammation and pulmonary fibrosis. RT-PCR analysis demonstrated substantial increases in IL-4, IL-5, IL-6, IL-13, and Col1a1 transcripts, indicating a Th2-dominant immune profile and enhanced fibrotic activity. The minimal differences in TGF-β expression between Asp f1- and saline-treated mice indicate that fibrosis in Yama mice may proceed via a TGF-β-independent pathway. These findings establish the Yama mouse as a novel model for ABPA research, closely replicating the immunopathological features of severe human ABPA. This model provides a reliable platform to investigate eosinophil-driven lung fibrosis mechanisms and evaluate hypersensitivity responses contributing to human ABPA onset and progression.

#3

Iron induces Aspergillus proteases in cystic fibrosis allergic bronchopulmonary aspergillosis.

American journal of respiratory cell and molecular biology2026 Feb 01

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity disease triggered by inhaled Aspergillus -fumigatus (Af) spores (i.e., conidia), in persons with cystic fibrosis (CF). High iron levels have been commonly described in CF respiratory secretions. Af proteases cause a severe allergic immune response, leading to pulmonary exacerbations and progressive lung function decline. The stimuli that promote Af proteases in ABPA are poorly understood. Determine if airway iron is a critical factor in CF-ABPA by regulating fungal protease production. We used transcriptomics and proteomics to investigate the role of iron in stimulating the production of Af proteases and evaluated the impact of these iron-induced Af proteases on the Th2 immune response in CF bronchial epithelial (CFBE) cells and in a CF-ABPA mouse model. Transcriptional analysis showed a significant upregulation of Af proteases with exposure to iron and a downregulation with iron chelation. This finding was validated in secretome studies showing that Af-culture filtrates (Af-cf) from iron-exposed conidia contained significantly higher levels of 14 proteases compared to controls. Exposure to iron-primed Af-cf increased the production of Th2 promoting cytokines (IL-33, IL-25 and TSLP) in CFBE cells compared to the wild type cells. In vivo, inoculation of CF mice with iron-primed Af conidia led to higher levels of serum IgE and Th2 cytokines (IL-4, IL-5, IL-9, IL-13) in lung tissue. These findings suggest that airway iron is a potent stimulus for Af proteases and represents a modifiable risk factor and potential therapeutic target for CF-ABPA.

#4

Isolated right ventricular löffler endocarditis secondary to allergic bronchopulmonary aspergillosis.

European heart journal. Case reports2026 Feb
#5

Pharmacist-Led Full-Course Pharmaceutical Care Model in Allergic Bronchopulmonary Aspergillosis: A Case Report-Based Approach to Optimizing Multidisciplinary Management.

Infection and drug resistance2026

The management of allergic bronchopulmonary aspergillosis (ABPA) is complicated by prolonged, multi-drug regimens that carry a high risk of multi-system adverse drug reactions (ADRs). This complexity underscores the need for integrated, continuous pharmaceutical care to optimize safety and efficacy, yet standardized models for such care are lacking. We report the case of a patient with ABPA and comorbid chronic hepatitis B, who had a history of failed ABPA therapy. During the current therapeutic course, the patient not only sequentially developed steroid-induced diabetes, drug-induced liver injury, hyperlactatemia, visual disturbances, phototoxicity, and hypokalemia but also progressed to treatment-dependent ABPA. The patient successfully completed the over-two-year protocol through a pharmacist-led full-course pharmaceutical care model that integrated regimen evaluation, efficacy monitoring, comprehensive adverse reaction management, discharge education, and follow-up. This case demonstrates that a full-course pharmaceutical care model enables timely detection and management of complex ADRs, optimizes therapeutic outcomes, and supports multidisciplinary decision-making. The model illustrates the pivotal role of the clinical pharmacist in improving medication safety and efficacy in ABPA, offering a replicable framework for promoting integrated, patient-centered care in pulmonary fungal diseases.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.256 artigos no totalmostrando 196

2026

Pharmacist-Led Full-Course Pharmaceutical Care Model in Allergic Bronchopulmonary Aspergillosis: A Case Report-Based Approach to Optimizing Multidisciplinary Management.

Infection and drug resistance
2026

From Aspergillus fumigatus pathogen surveillance to Aspergillus disease surveillance.

The Journal of hospital infection
2026

[Allergic bronchopulmonary aspergillosis in internal medicine].

La Revue de medecine interne
2026

Increased serum antibody responses to Aspergillus fumigatus and house dust mite antigens in dogs with idiopathic eosinophilic bronchopneumopathy.

Journal of veterinary internal medicine
2026

Asthma and Allergic Bronchopulmonary Aspergillosis: Understanding, Insights, and State-of-the-Art.

Journal of inflammation research
2026

Nebulised antifungal therapy in allergic bronchopulmonary aspergillosis in a patient with treatment-limiting comorbidities.

Medicina clinica
2026

Stepwise, precision-based management of allergic Bronchopulmonary Aspergillosis/Mycosis: A real-life multicenter study.

Allergologia et immunopathologia
2026

Protocol for a systematic literature review and network meta-analysis of the evidence for therapies in allergic bronchopulmonary aspergillosis (ABPA).

Systematic reviews
2026

High total serum IgE level at diagnosis was associated with a progressive decline in lung function in asthmatic patients with allergic bronchopulmonary mycosis.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2026

Biologics Use in Eosinophilic Lung Disease: Controversies and Consensus.

The journal of allergy and clinical immunology. In practice
2026

Differential Diagnosis of Eosinophilic Lung Diseases.

The journal of allergy and clinical immunology. In practice
2026

[A case of allergic bronchopulmonary aspergillosis complicated by pinworm infection in a child: immune interaction mechanism and stepwise treatment strategy].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2026

Radiological Phenotypes of Bronchiectasis Based on Airway Generation.

Biomedicines
2026

Fluorodeoxyglucose (FDG)-Avid Upper-Lobe Mass Mimicking Malignancy in an Elderly Patient With Allergic Bronchopulmonary Aspergillosis: A Case Report.

Cureus
2026

Allergic bronchopulmonary aspergillosis in a patient without history of asthma: a case report.

Medical mycology case reports
2026

How Should IgG Seroconversion to Aspergillus fumigatus be Interpreted in Children With Cystic Fibrosis.

Canadian respiratory journal
2026

Cystic fibrosis complicated by allergic bronchopulmonary aspergillosis in a Chinese adolescent: a case report and literature review.

AME case reports
2026

Allergic bronchopulmonary aspergillosis or tropical pulmonary eosinophilia: discriminatory potential of recombinant Aspergillus fumigatus antigens.

The journal of allergy and clinical immunology. In practice
2026

Isolated right ventricular löffler endocarditis secondary to allergic bronchopulmonary aspergillosis.

European heart journal. Case reports
2025

Concurrent Elevation of CEA and CA 19-9 in a Patient with Allergic Bronchopulmonary Aspergillosis: A Case Report and Literature Review.

Annals of clinical and laboratory science
2026

[Allergic bronchopulmonary aspergillosis-essential knowledge for radiology].

Radiologie (Heidelberg, Germany)
2026

Comorbidities in pediatric cystic fibrosis: ABPA, celiac disease and prediabetes in Georgia.

Respiratory medicine
2026

Anti-inflammatory therapies for bronchiectasis.

Current opinion in infectious diseases
2026

Common inflammatory markers predict risk of ABPA development in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2025

A Rare Case of Allergic Bronchopulmonary Aspergillosis With Endobronchial Aspergilloma Causing Total Lung Collapse.

Cureus
2026

Pathogen-specific IgE-reactive cytosolic allergenic epitopes of Aspergillus fumigatus for immunodiagnostic/immunotherapeutic applications against allergic aspergillosis.

Annals of clinical microbiology and antimicrobials
2026

[How do I treat : allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].

Revue medicale de Liege
2025

Allergic bronchopulmonary aspergillosis and Aspergillus-related airway diseases in bronchiectasis: a narrative review.

Journal of thoracic disease
2025

Aspergillus sensitisation & allergic bronchopulmonary aspergillosis in chronic obstructive pulmonary disease: Redefining a treatable trait.

The Indian journal of medical research
2026

Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays.

Allergy and asthma proceedings
2026

Invasive pulmonary aspergillosis with no abnormal immunity overlapped with allergic bronchopulmonary aspergillosis: A case report.

Medicine
2026

The association between different regimens of glucocorticoid and antifungal treatment with the prognosis of allergic bronchopulmonary aspergillosis: a retrospective cohort study.

Annals of medicine
2025

Off-label applications of omalizumab: Current insights and perspectives.

The World Allergy Organization journal
2025

Tezepelumab After Mepolizumab in Allergic Bronchopulmonary Mycosis: A Case Report.

Cureus
2025

Evaluation and differential diagnosis of eosinophilia: A tertiary allergy center experience.

Tuberkuloz ve toraks
2025

An Atypical Presentation of Allergic Bronchopulmonary Aspergillosis.

Cureus
2025

Allergic Bronchopulmonary Aspergillosis (ABPA) Without Asthma: A Case Report and Review of the ABPA Imaging Spectrum.

Cureus
2025

Allergic Bronchopulmonary Aspergillosis Presenting With Pulmonary Solid Lesions and Elevated Serum Carcinoembryonic Antigen Mimicking Lung Cancer.

The American journal of case reports
2025

Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma Management.

Archivos de bronconeumologia
2026

Effectiveness and Safety of Mepolizumab in Allergic Bronchopulmonary Aspergillosis (ABPA): Real-World Experience From a Chinese Retrospective Case Series.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2025

Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case series and literature review.

BMC pulmonary medicine
2025

Allergic Bronchopulmonary Aspergillosis Presenting as Pyopneumothorax: Expanding the Clinical Spectrum.

Annals of African medicine
2026

Occurrence of allergic bronchopulmonary aspergillosis in Chinese adults with asthma and COPD comorbidity.

Respiratory medicine
2025

Pleuroparenchymal aspergillus infection in allergic bronchopulmonary aspergillosis.

Journal of postgraduate medicine
2026

Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisation.

Mucosal immunology
2026

Establishment of a novel murine model of allergic bronchopulmonary aspergillosis using an eosinophilic mutant mouse.

The Journal of veterinary medical science
2025

Immune markers for pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a narrative review.

Frontiers in immunology
2025

[Pulmonary imaging of cystic fibrosis with a focus on children and adolescents].

Radiologie (Heidelberg, Germany)
2026

Validation of the Bronchiectasis Health Questionnaire in Bronchiectasis and Estimation of the Meaningful Score Difference for ABPA.

The journal of allergy and clinical immunology. In practice
2025

Invasive Aspergillosis with Secondary Bacterial Infection with E. Coli: A Case Report.

Journal of pharmacy &amp; bioallied sciences
2025

Progression of Structural Lung Disease in Different Aspergillus fumigatus Disease Phenotypes in Children with CF.

Journal of fungi (Basel, Switzerland)
2025

Arterialized oxygen tension and unfavorable clinical outcomes in pediatric cystic fibrosis.

Frontiers in pediatrics
2025

Prevalence of Allergic Bronchopulmonary Aspergillosis in Severe Asthma Patients Presenting to a Tertiary Care Hospital in North West India.

The Journal of the Association of Physicians of India
2025

[Late diagnosis of allergic pulmonary aspergillosis in a patient with post-tuberculosis pulmonary sequelae: a fatal case].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

Aspergillus fumigatus is influenced by mucus accumulation, airway inflammation and cystic fibrosis transmembrane conductance regulator function.

ERJ open research
2026

Optimal ImmunoCAP Aspergillus fumigatus-Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2025

Prevalence of Allergic Bronchopulmonary Aspergillosis in Bronchial Asthma Patients: A Retrospective Observational Study.

Cureus
2026

Iron induces Aspergillus proteases in cystic fibrosis allergic bronchopulmonary aspergillosis.

American journal of respiratory cell and molecular biology
2025

Case Report: Aspergillus fumigatus-associated plastic bronchitis in a pediatric patient with cystic fibrosis complicated by allergic bronchopulmonary aspergillosis.

Frontiers in pediatrics
2024

Knowledge Mapping of Aspergillus-Related Research in Respiratory Medicine: A Bibliometric Analysis Based on English-Language Articles Spanning 1975 to 2022.

Canadian respiratory journal
2025

Three Biologic-Naïve Patients with Allergic Bronchopulmonary Aspergillosis Showing Significant Clinical Improvement with Tezepelumab.

Journal of asthma and allergy
2025

Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2025

Healthy Homes, Healthy Lungs: The Role of Home Insulation in Environmental Impact on People With Cystic Fibrosis.

Pediatric pulmonology
2025

Allergic Bronchopulmonary Aspergillosis Misdiagnosed as Non-resolving Pneumonia: A Case Report.

Saudi journal of medicine &amp; medical sciences
2026

Monitoring treatment response using serial PTX3 levels in chronic and invasive pulmonary aspergillosis.

Clinica chimica acta; international journal of clinical chemistry
2025

Association between allergic bronchopulmonary aspergillosis or Aspergillus sensitization and tuberculosis: A systematic review of 607 cases.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2025

Evaluating the Role of Bronchoscopy in Allergic Bronchopulmonary Aspergillosis/Allergic Bronchopulmonary Mycosis: Evidence, Utility, and Caution.

The journal of allergy and clinical immunology. In practice
2025

Concurrent strongyloidiasis and allergic bronchopulmonary aspergillosis complicating diagnosis: case report.

Frontiers in medicine
2025

Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences. An EAACI Task Force Report.

Allergy
2025

Serum Mannose-Binding Lectin Levels in Asthma and Allergic Bronchopulmonary Aspergillosis.

Mycopathologia
2026

The Triad of Pathogenesis in Allergic Bronchopulmonary Aspergillosis: Interactions among <italic>Aspergillus fumigatus</italic>, Epithelium, and Immunity.

International archives of allergy and immunology
2025

Condition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on Aspergillus fumigatus growth.

Microbiology spectrum
2025

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report.

Frontiers in pharmacology
2025

Diagnostic and Therapeutic Challenges in Bronchiectasis With Concurrent Allergic Bronchopulmonary Aspergillosis and Non-tuberculous Mycobacterial Infection: A Case Report.

Cureus
2025

Allergic bronchopulmonary aspergillosis, bronchiectasis severity, and clinical outcomes.

The journal of allergy and clinical immunology. In practice
2025

Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making.

Allergy and asthma proceedings
2025

Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis.

Allergy and asthma proceedings
2025

Nanostructured lipid carriers-loaded dry powder inhaler for pulmonary delivery of amphotericin B in treatment of allergic bronchopulmonary aspergillosis.

International journal of pharmaceutics
2025

Pulmonary aspergillosis in patients with asthma.

Journal of infection in developing countries
2025

Cut-Offs and Diagnostic Performance of IgG Against Recombinant Aspergillus fumigatus Antigens in Differentiating ABPA From Asthma.

Mycoses
2025

Allergic Bronchopulmonary Aspergillosis With Elevated Serum Tumour Marker Levels.

Respirology case reports
2025

[Complete left lung atelectasis as the initial presentation of allergic bronchopulmonary aspergillosis: a case report].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2025

Serum periostin and carcinoembryonic antigen for diagnosing and assessing response in allergic bronchopulmonary aspergillosis.

Lung India : official organ of Indian Chest Society
2025

International consensus statement on routine blood testing in primary ciliary dyskinesia.

ERJ open research
2025

Diseases Common in Persons With Cystic Fibrosis Among CFTR Heterozygotes.

JAMA internal medicine
2025

Pulmonary Aspergillosis: Epidemiology and unresolved diagnostic challenges - insights from a two-year retrospective cohort study in Marseille.

Respiratory medicine
2025

Paradoxical effects of dupilumab in allergic bronchopulmonary aspergillosis: Resolution of mucus plugging but induction of eosinophilic pneumonia.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2025

Clinical characteristics and risk factors analysis of allergic bronchopulmonary aspergillosis combined with bronchiectasis.

Frontiers in medicine
2025

New insights into the treatment of asthma complicated by allergic bronchopulmonary aspergillosis.

Expert review of respiratory medicine
2025

A Case of Cryobiopsy of a Large Allergic Bronchopulmonary Aspergillosis-Associated Mucus Plug.

Respirology case reports
2025

Mucoid impaction due to broncholithiasis with a clinical presentation mimicking allergic bronchopulmonary aspergillosis.

The Journal of asthma : official journal of the Association for the Care of Asthma
2025

Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis.

The journal of allergy and clinical immunology. In practice
2025

Successful treatment of an allergic bronchopulmonary aspergillosis patient with inhaled antifungal opelconazole.

The journal of allergy and clinical immunology. In practice
2025

Clinical Characteristics of Difficult-To-Treat Allergic Bronchopulmonary Aspergillosis and Its Prediction Score.

Allergy
2025

Non-Cystic Fibrosis Bronchiectasis in Adults: A Review.

JAMA
2025

Roles of Mycological and Pathological Examinations of Bronchoscopic Specimens in the Diagnosis of Allergic Bronchopulmonary Aspergillosis/Mycosis.

The journal of allergy and clinical immunology. In practice
2025

Serum Type 2 Cytokine Levels Are Elevated in a Chronic Pulmonary Aspergillosis Subgroup with High Serum Total Immunoglobulin E Level.

Journal of fungi (Basel, Switzerland)
2025

Early Intervention with Mepolizumab, Corticosteroids, and Intravenous Immunoglobulin for Dupilumab-Triggered Eosinophilic Granulomatosis with Polyangiitis: A Case Report.

Journal of asthma and allergy
2025

Low Th17 cells in patients with cystic fibrosis and allergic broncho-pulmonary aspergillosis.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

Clinical characteristics and gene analysis in 7 Chinese children with cystic fibrosis.

Critical reviews in eukaryotic gene expression
2025

Treatment of allergic bronchopulmonary aspergillosis with biologics.

Chinese medical journal pulmonary and critical care medicine
2025

A 48-year-old male with allergic bronchopulmonary aspergillosis: a rare case report.

Annals of medicine and surgery (2012)
2025

Allergic bronchopulmonary aspergillosis in cystic fibrosis: Case-control study from the French registry.

Medical mycology
2025

Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.

Chest
2025

Proposal and Verification of New Revised Criteria for ABPA/ABPM Diagnosis.

Journal of asthma and allergy
2025

Anti-interleukin-5 efficacy in an inclisiran-triggered eosinophilic myocarditis: a case report.

European heart journal. Case reports
2025

Miliary Nodules in the Lungs Not Always Due to Tuberculosis: A Report of a Rare Case.

Cureus
2025

2024 imaging criteria for allergic bronchopulmonary aspergillosis: which diagnostic cut-offs? Are chest radiograph and CT comparable?

The European respiratory journal
2025

Aspergillus in Children and Young People with Cystic Fibrosis: A Narrative Review.

Journal of fungi (Basel, Switzerland)
2025

CFTR negatively reprograms Th2 cell responses, and CFTR potentiation restrains allergic airway inflammation.

JCI insight
2025

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).

Thorax
2025

Impact of Bronchiectasis Severity on Clinical Outcomes in Patients With Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study.

The journal of allergy and clinical immunology. In practice
2025

Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis.

The journal of allergy and clinical immunology. In practice
2025

Allergic Bronchopulmonary Aspergillosis, a Masquerader: Unveiling a Case of Nonresolving Pneumonia in an Asthmatic Patient.

The Journal of the Association of Physicians of India
2025

[Atelectasis caused by mucus stasis].

Nederlands tijdschrift voor geneeskunde
2025

High level of initial Aspergillus fumigatus-specific IgE links increased risk of exacerbation in allergic bronchopulmonary aspergillosis patients.

Respiratory research
2025

Pseudomembranous Aspergillus tracheobronchitis: A Rare Manifestation of Invasive Aspergillosis in a Immunocompetent Patient.

Infection and drug resistance
2025

Successful treatment by switching from benralizumab to dupilumab in a patient with allergic bronchopulmonary mycosis caused by Schizophyllumcommune.

Respiratory investigation
2025

Forgotten Foreign Body Aspiration Presenting as Allergic Bronchopulmonary Aspergillosis: A Case Report.

Cureus
2025

Efficacy and Safety of Dupilumab Treatment for Adult Allergic Bronchopulmonary Aspergillosis: A Real-World Analysis of 16 Cases in China.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2025

Pneumothorax as first presentation of 'ABPA sans asthma'.

Lung India : official organ of Indian Chest Society
2025

Longitudinal Study on Clinical Predictors for Allergic Bronchopulmonary Aspergillosis in Children and Young People with Cystic Fibrosis Highlights the Impact of Infection with Aspergillus and Pseudomonas and Ivacaftor Treatment.

Journal of fungi (Basel, Switzerland)
2025

Allergic Bronchopulmonary Aspergillosis in Patients With Prior Pulmonary Tuberculosis: A Study on the Burden, Clinic-Radiological Features, Treatment Outcomes and Comparison With Chronic Pulmonary Aspergillosis and Post-Tubercular Lung Disease Patients.

Mycoses
2025

Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Inhaled Voriconazole in Healthy Volunteers and Subjects With Stable Asthma.

Pharmacology research &amp; perspectives
2025

Increased NFAT and NFκB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of cystic fibrosis.

PLoS pathogens
2025

Coexistence of Asymptomatic Allergic Bronchopulmonary Aspergillosis and Active Pulmonary Tuberculosis: Case Report.

Infection and drug resistance
2025

[Bronchiectasis in patients with severe asthma : a narrative literature review].

Revue medicale de Liege
2025

Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016-2022.

PloS one
2025

Correlation of Aspergillus fumigatus Sensitization with Mucus Plugging in COPD.

International journal of chronic obstructive pulmonary disease
2025

An immunological perspective in the treatment strategy of allergic bronchopulmonary aspergillosis.

QJM : monthly journal of the Association of Physicians
2025

Pulmonary Aspergillus overlap syndrome in a patient with bronchial asthma.

BMJ case reports
2025

Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection.

Lung
2025

Unexpected radiological presentation in allergic bronchopulmonary aspergillosis: multiple lung masses.

Thorax
2024

Two different diseases in two adolescent girls with the same clinic: Allergic bronchopulmonary aspergillosis.

Tuberkuloz ve toraks
2024

Clinical Relevance of Elevated Serum Carcinoembryonic Antigen in Allergic Bronchopulmonary Aspergillosis/Mycosis: A Multicenter Retrospective Study.

Journal of asthma and allergy
2025

Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis.

The journal of allergy and clinical immunology. Global
2025

High-attenuation mucus and acute atelectasis in allergic bronchopulmonary aspergillosis.

QJM : monthly journal of the Association of Physicians
2025

Signaling events driving Aspergillus fumigatus-induced eosinophil activation.

International journal of medical microbiology : IJMM
2025

Trends in the Treatment of Allergic Bronchopulmonary Aspergillosis.

Annals of the American Thoracic Society
2025

Refractory phenotype of Aspergillus-sensitized asthma with bronchiectasis and allergic bronchopulmonary aspergillosis.

The journal of allergy and clinical immunology. Global
2024

A multidimensional grading system for ABPA treatment escalation within the first year: The HEID score.

The World Allergy Organization journal
2024

[Application of Aspergillus-specific immunoglobulin G antibody in the management of pulmonary aspergillosis].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

[Evolution of diagnostic criteria for allergic bronchopulmonary aspergillosis].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2025

A decision tree analysis to evaluate the optimal approach to screen allergic bronchopulmonary aspergillosis in asthmatic patients.

The Journal of asthma : official journal of the Association for the Care of Asthma
2024

[Allergic bronchopulmonary aspergillosis in a patient with diabetes mellitus as the only risk factor].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2024

Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis.

Mycoses
2025

Allergic bronchopulmonary aspergillosis: A treatable trait to consider in chronic obstructive pulmonary disease?

Medicina clinica
2024

Long-Term Antifungal Treatment in a Patient With Confirmed Allergic Bronchopulmonary Aspergillosis.

Cureus
2025

Asthma and respiratory comorbidities.

The Journal of allergy and clinical immunology
2024

Fungal disease incidence and prevalence in Iraq - Preliminary estimates.

Journal de mycologie medicale
2025

Revised clinical practice guidelines for allergic bronchopulmonary aspergillosis/mycosis: A detailed and comprehensive update.

Chinese medical journal
2024

Managing diagnostic complexity: Allergic bronchopulmonary aspergillosis (ABPA) mimicking asthma exacerbation and infections in pediatric cases.

Journal of family medicine and primary care
2024

EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis.

Mycoses
2025

Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry.

Chest
2025

In silico B-cell epitope prediction and molecular docking of Aspergillus allergens targeting improved ABPA diagnosis.

The Journal of asthma : official journal of the Association for the Care of Asthma
2024

[Medical clinical diagnostics for indoor mould exposure - Update 2023 (AWMF Register No. 161/001)].

Pneumologie (Stuttgart, Germany)
2024

[Chinese expert consensus on the etiological diagnosis of adult bronchiectasis].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis.

Immunology and allergy clinics of North America
2025

The Real-World Effectiveness of Antifungals in People with Cystic Fibrosis and Aspergillus-Positive Cultures.

Annals of the American Thoracic Society
2024

Sex Differences in Allergic Bronchopulmonary Aspergillosis and its Impact on Exacerbations.

Mycopathologia
2024

Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019.

BMC infectious diseases
2024

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators.

Journal of fungi (Basel, Switzerland)
2024

Long-Term Outcomes of Allergic Bronchopulmonary Aspergillosis and Aspergillus Colonization in Children and Adolescents with Cystic Fibrosis.

Journal of fungi (Basel, Switzerland)
2024

Co-Existing Fungi: An Unforeseen Combo Creating a Dilemma in Diagnostic Morale.

Cureus
2024

Coinfection of Klebsiella pneumoniae and Aspergillus in a patient with chronic obstructive pulmonary disease post cardiac arrest: a case report.

Journal of medical case reports
2024

Is the Prevalence of Allergic Bronchopulmonary Aspergillosis Greater in Severe Asthma?

The journal of allergy and clinical immunology. In practice
2024

[BRONCHOPULMONARY ASPERGILLOSIS WITH COMORBID GRANULOMATOUS POLYANGIITIS IN A PATIENT WHO PRESENTED WITH EXOPHTHALMOS: A CASE REPORT].

Arerugi = [Allergy]
2024

Occupational Lung Disease Causing Allergic Bronchopulmonary Aspergillosis: A Case Report.

Cureus
2025

Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?

Internal medicine (Tokyo, Japan)
2024

Retrospective Comparison of Two Aspergillus IgG Enzyme Immunoassays for Diagnosing Pulmonary Aspergillosis.

Medical mycology journal
2024

Improvement of Mucoid Impaction with Dupilumab in a Severe Asthma Patient.

Maedica
2024

PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis.

The journal of allergy and clinical immunology. Global
2024

A Case Report of Navigating Dual Respiratory Challenges: From Pulmonary Tuberculosis (PTB) to Allergic Bronchopulmonary Aspergillosis (ABPA).

Cureus
2024

A Case Report of Central Bronchiectasis in a Poorly Controlled Asthmatic Adolescent With Allergic Bronchopulmonary Aspergillosis and Secondary Spontaneous Pneumothorax.

Cureus
2024

Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators.

The journal of allergy and clinical immunology. Global
2024

Population prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in COPD subjects in North India.

Mycoses
2024

Aspergillus-sensitized asthma in children.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2024

The role of radiological imaging in the management of severe and difficult-to-treat asthma.

Breathe (Sheffield, England)
2024

Allergic bronchopulmonary mycosis in Schizophyllum commune with positive Aspergillus-specific IgE antibodies: A case report.

Respirology case reports
2024

Development of allergic bronchopulmonary aspergillosis in a patient with nontuberculous mycobacterial-pulmonary disease successfully treated with dupilumab: A case report and literature review.

Respirology case reports
2024

Allergic bronchopulmonary aspergillosis with metachronous isolation of three distinct Aspergillus species.

Respirology case reports
2024

Long-term use of omalizumab in patients with allergic bronchopulmonary aspergillosis: a tertiary-level care center experience.

The Journal of asthma : official journal of the Association for the Care of Asthma
2024

[Allergic bronchopulmonary aspergillosis with low serum IgE: a case report].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

[Expert consensus on the diagnosis and treatment of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

[Issues in the diagnosis and evaluation of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.

Lung
2024

Allergic broncho-pulmonary aspergillosis: Old disease, new frontiers.

Respirology (Carlton, Vic.)
2024

Allergic Bronchopulmonary Aspergillosis (ABPA) With Colonized Aspergillus fumigatus Detected by Metagenomic Next-Generation Sequencing on Tissue Samples: A Distinct Subset of ABPA With a Higher Risk of Exacerbation.

The clinical respiratory journal
2024

Type 2 Biomarkers and Their Clinical Implications in Bronchiectasis: A Prospective Cohort Study.

Lung
2024

Characterization of Aspergillus fumigatus secretome during sublethal infection of Galleria mellonella larvae.

Journal of medical microbiology
2024

Distribution of Aspergillus species and risk factors for aspergillosis in mainland China: a systematic review.

Therapeutic advances in infectious disease
2024

Allergic bronchopulmonary aspergillosis in a lung transplant recipient treated with mepolizumab.

Clinical immunology (Orlando, Fla.)
2024

Silicosis-Allergic Bronchopulmonary Aspergillosis Overlap-A Rare Duet!

Indian journal of occupational and environmental medicine
2024

Fractional exhaled nitric oxide, a potential biomarker for evaluating glucocorticoids treatment and prognosis in allergic bronchopulmonary aspergillosis.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2024

AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001.

Allergologie select
2024

T-cells and precision medicine for allergic bronchopulmonary aspergillosis.

The European respiratory journal
Ver todos os 1.256 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Aspergilose broncopulmonar alérgica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Aspergilose broncopulmonar alérgica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. [A case of allergic bronchopulmonary aspergillosis complicated by pinworm infection in a child: immune interaction mechanism and stepwise treatment strategy].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics· 2026· PMID 41766159mais citado
  2. Establishment of a novel murine model of allergic bronchopulmonary aspergillosis using an eosinophilic mutant mouse.
    The Journal of veterinary medical science· 2026· PMID 41224326mais citado
  3. Iron induces Aspergillus proteases in cystic fibrosis allergic bronchopulmonary aspergillosis.
    American journal of respiratory cell and molecular biology· 2026· PMID 40965296mais citado
  4. Isolated right ventricular l&#xf6;ffler endocarditis secondary to allergic bronchopulmonary aspergillosis.
    European heart journal. Case reports· 2026· PMID 41635603mais citado
  5. Pharmacist-Led Full-Course Pharmaceutical Care Model in Allergic Bronchopulmonary Aspergillosis: A Case Report-Based Approach to Optimizing Multidisciplinary Management.
    Infection and drug resistance· 2026· PMID 41868025mais citado
  6. Predicting Mortality in Intensive Care Unit Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) Using an Interpretable Machine Learning Model: A Retrospective Cohort Study.
    Can Respir J· 2026· PMID 41986939recente
  7. Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis: A 24-Month Italian National Registry Study.
    J Clin Med· 2026· PMID 41977003recente
  8. [A CASE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS THAT DEVELOPED FROM DE NOVO SENSITIZATION IN A STABLE NON-ATOPIC ASTHMA, DIAGNOSED BY COMPUTED TOMOGRAPHY].
    Arerugi· 2026· PMID 41967937recente
  9. Frequency of Aspergillus fumigatus sensitization and its impact on longitudinal asthma control: a 12-week prospective cohort study.
    Monaldi Arch Chest Dis· 2026· PMID 41949214recente
  10. Does ABPA Contribute to Bronchiectasis? A Structured Evaluation of Competing Hypotheses.
    Clin Exp Allergy· 2026· PMID 41943086recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1164(Orphanet)
  2. OMIM OMIM:103920(OMIM)
  3. MONDO:0015243(MONDO)
  4. GARD:602(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q1430844(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Aspergilose broncopulmonar alérgica
Compêndio · Raras BR

Aspergilose broncopulmonar alérgica

ORPHA:1164 · MONDO:0015243
Prevalência
Unknown
Herança
Not applicable
CID-10
B44.1+ · Aspergilose
CID-11
Ensaios
10 ativos
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0004031
Repurposing
3 candidatos
caspofungin"bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor"
itraconazolecytochrome P450 inhibitor
voriconazole
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades